|
FY2019
12 months to Mar 31, 2019
|
FY2015
12 months to Mar 31, 2015
|
FY2014
12 months to Mar 31, 2014
|
FY2013
9 months to Mar 31, 2013
|
|
|---|---|---|---|---|
| Revenue | ||||
| Service | ||||
| Product | ||||
| Total revenue | ||||
| Costs of revenue | ||||
| Service | ||||
| Product | ||||
| Total costs of revenue | ||||
| Gross margin | ||||
| Operating expenses | ||||
| Sales and marketing | ||||
| General and administrative (includes stock-based compensation costs of $0 and $1,950,482 issued to officer, directors and other related parties for the years ended March 31, 2019, and 2018, respectively) | ||||
| Research and development | ||||
| Depreciation | ||||
| Total operating expenses | ||||
| Income (loss) from operations | ||||
| Other income (expense) | ||||
| Interest and financing costs | ||||
| Total other income (expenses), net | ||||
| Net income (loss) before provision for income taxes | ||||
| Income tax expense | ||||
| Net income (loss) | ||||
| Deemed dividend related to beneficial conversion feature of Series B Preferred Stock | ||||
| Net income (loss) attributable to common stockholders | ||||
| Net income (loss) per share attributable to common stockholders: | ||||
| Basic | ||||
| Diluted | ||||
| Shares used in computing net income (loss) per share attributable to common stockholders: | ||||
| Basic | ||||
| Diluted | ||||
Loading...